Infusion Pump Fleet Failure Before Accreditation Audit
A 450-bed tertiary hospital in Lahore operates 380 volumetric infusion pumps. The biomedical engineering department has five technicians, one calibrated flow analyzer, and a PKR 6.0 million annual maintenance budget. During a pre-accreditation audit, 120 pumps from a 2014 batch failed a spot check: at 5 mL/h the delivered volume was 8–11% below setpoint against a manufacturer tolerance of ±5%, and battery runtime was 22 minutes against a 4-hour specification. Oncology reported 12 suspected under-infusion events in six months, but no patient harm was confirmed. The vendor offers a board-level retrofit at PKR 18,000 per pump with a 90-day lead time; a new pump costs PKR 140,000. The hospital cannot replace the whole fleet this year. Nursing refuses to withdraw all 120 pumps because 60 are in active use in critical care. The audit is in eight weeks.
1. Propose a risk-based disposition plan for the 120 affected pumps over the next eight weeks. Identify which pumps should be withdrawn, which may remain in service, and the acceptance criteria you would apply.
Read the worked answer
Start from use context, not device age. The failure mode is low-rate under-delivery, so risk is highest where a small volume error becomes a large dose error: neonatal and paediatric infusions, vasopressors, insulin, chemotherapy, and anticoagulants. The 8–11% error at 5 mL/h exceeds the ±5% tolerance and is not acceptable for those applications.
A defensible plan is:
- Immediately withdraw all 120 pumps from neonatal, oncology, and vasopressor use; that removes roughly 30–40 pumps from the highest-risk locations.
- Keep the remaining pumps only for low-risk adult maintenance fluids, with a documented label, daily flow check at the actual rate used, and a four-hour battery test before each shift.
- Send all 120 for retrofit in batches, prioritising critical-care and oncology units; do not release a pump until it passes flow verification at 1, 5, 25 and 50 mL/h and delivers at least 2 hours of battery runtime under load.
- Rent 15–20 certified pumps to cover the retrofit gap, because nursing cannot absorb a 60-pump loss.
The acceptance criteria should be the manufacturer’s ±5% at each tested rate, no visible battery swelling, and a passed electrical safety test. With a PKR 6 million budget, retrofitting all 120 at PKR 2.16 million plus rental is feasible; replacing even 40 pumps would cost PKR 5.6 million and consume nearly the whole budget without fixing the other 80.
2. Should the 12 suspected under-infusion events be reported externally? Justify your decision and outline the documentation and corrective-action steps.
Read the worked answer
The trigger is not proven patient harm; it is a device malfunction with a plausible serious-injury pathway. Twelve suspected under-infusion events, plus a measured 8–11% flow error, meet the threshold for internal investigation and likely external reporting. Under Pakistan’s medical-device vigilance expectations, the hospital should notify the manufacturer and DRAP through the adverse-event reporting route, while preserving the pumps and records. The report should state that causality is not established; under-reporting because no harm was confirmed would be the wrong judgement.
Internally, open a CAPA: record pump serial numbers, infusion rates, drugs, lot numbers, and event times; interview nursing; review infusion logs; and test a sample of returned pumps on the calibrated analyzer. Separate device error from user error by checking set calibration, tubing compatibility, and vertical height. The vendor’s retrofit should be treated as a field safety corrective action if the same failure mode is confirmed across the batch, not merely a commercial upgrade.
Close the CAPA only when the retrofit is verified by independent testing, nursing has been retrained on low-rate alarms, and a trend review shows no recurrence over three months. Notify accreditation surveyors of the interim controls, because the audit will examine whether the hospital detected and acted on the signal.
3. The vendor offers retrofit at PKR 18,000 per pump versus PKR 140,000 for a new pump. How would you justify the spending decision to hospital management, and what residual risk remains?
Read the worked answer
Compare lifecycle risk and cost, not unit price alone. Retrofitting all 120 pumps costs PKR 2.16 million; replacing 120 costs PKR 16.8 million, or PKR 5.6 million for only 40 units. The retrofit preserves fleet size and addresses the identified failure mode, so it is the better first intervention. However, the 2014 pumps also have battery ageing: a 22-minute runtime will not be fixed by a flow-board retrofit unless batteries are replaced. Add battery replacement and rental to the business case.
A reasonable request is PKR 2.16 million for retrofit, PKR 0.6–0.9 million for batteries and rental, and PKR 1.2 million held for independent verification and contingency. This stays within the PKR 6 million budget and leaves capacity for other equipment. Management should approve on condition that the vendor provides a written specification, warranty, and verification test data.
Residual risk remains because retrofit does not restore new-device reliability. Set a three-year replacement horizon for the 2014 batch, monitor flow-error trends quarterly, and require a 2-hour battery pass before clinical release. If the retrofit fails verification on more than 10% of units, switch to phased replacement rather than continuing to repair.